Surgical Innovation Associates

About:

Surgical Innovation Associates is a developer of implantable polymeric surgical devices for plastic, reconstructive, and general surgery.

Website: https://www.sia.health/

Top Investors: New York Angels, THE CATALYTIC IMPACT FOUNDATION (CIF), Pioneer Healthcare Partners, Gopher Angels, Harvard Business School Angels Chicago

Description:

Surgical Innovation Associates, Inc. (“SIA”, sia.health) is a commercial stage medical device company, committed to raising the standard of care in plastic, reconstructive, and general surgery and lowering systemic costs through “for surgeon, by surgeon” implantable device innovation. Headquartered in downtown Chicago, Illinois, SIA’s proximity to academia and world-leading healthcare institutions has created the ideal ecosystem for the translation of concepts into devices to meet key clinical needs. The company’s flagship product family, DuraSorb® Monofilament Mesh is on the market and indicated for use in reinforcement of soft tissues where weakness exists. DuraSorb® was specifically designed for plastic, reconstructive, and general surgery and is US FDA 510(k) cleared and CE marked. The product is available in multiple sizes, and is part of a growing pipeline of novel medical devices made from commonly-used resorbable polymers.